At a glance
- A routine periodic screening repeats a fixed preventive panel on a set cycle; a longevity checkup adds a wider, questionnaire-tailored set of markers.
- Per MP Check, a single visit covers more than 30 biometric parameters across a broad test range, from a finger-prick capillary sample.
- Neither is a diagnosis: screening flags areas worth monitoring and routes a person to a treating physician when a result warrants follow-up.
- MP Check runs clinical screening at home or at the office, with no fasting and most results interpreted on site by a specialist doctor.
MP Check
Published:
The difference is one of scope and intent, not of medical category. A routine periodic screening is the familiar preventive panel: a standard set of tests repeated on a fixed cycle. A longevity checkup widens that idea into a protocol tailored by questionnaire, which can add measures such as RMR (resting metabolic rate) to build a picture of one person's health over time. Both are screening (testing a healthy person to flag areas worth monitoring before symptoms appear) and neither is a diagnosis. A result that warrants attention routes the person onward to a treating physician. MP Check performs clinical screening at home or at the workplace, with a personal protocol set by questionnaire, over 30 biometric parameters, and capillary blood taken by finger prick, so that blood draw involves no needle, no vein puncture and no fasting.
What exactly is a longevity checkup, and what does it try to detect?
A longevity checkup is a proactive early-detection screening programme for adults who currently feel well. Rather than responding to symptoms, it looks for early risk findings in a person who has none yet. It belongs to preventive medicine: planned screening to detect and prevent disease early, before symptoms appear.
What does a longevity checkup typically measure?
As general information, longevity-oriented checkups tend to group their measures into a few broad areas. Which ones a given provider offers varies:
- Biometric parameters: body measurements tracked across visits, so later results have a baseline to compare against.
- Blood and urine tests: laboratory measures that can shift before symptoms do.
- Metabolic measures: for example RMR (resting metabolic rate), the energy the body burns at rest.
- Questionnaire-selected checks: tests chosen by age, sex, history and risk rather than from a fixed list.
Where does screening end and diagnosis begin?
Screening is not diagnosis. A flagged result is a reason for further investigation by a treating physician, not a verdict. MP Check performs screening and routes people onward. As a general rule, diagnosis and treatment are decisions for a treating physician.
How does a routine periodic screening differ in purpose, scope and cadence?
A routine periodic screening is a preventive check on a fixed schedule for people without symptoms. It differs from a longevity checkup mainly in who defines the panel and how often it runs.
The criteria that separate them:
- Purpose: population-level detection versus an individual risk profile. This decides whether a check aims to catch common conditions efficiently across many people or to build one person's picture over time.
- Panel selection: who chooses which tests run. This matters when a standard panel leaves known personal or family risks uncovered.
- Cadence: a fixed interval versus an interval set by risk. This matters when circumstances have changed since the last check.
- Setting and access: where the check physically happens, which drives whether people use the benefit.
- Follow-through: how results reach a clinician who can act on them.
| Criterion | Routine periodic screening | Longevity checkup |
|---|---|---|
| Purpose | Early detection across a population; continuity of care | Broader picture driven by an individual risk profile |
| Panel selection | Age- and sex-based standard set | Tailored panel, typically built from a health questionnaire |
| Cadence | Fixed, recurring interval | Set by risk and previous results |
| Setting | Clinic or hospital visit | Delivered where the person is; MP Check brings clinical screening to the home or workplace |
| Follow-through | Handled within regular care | Findings discussed and the person routed onward |
Both layers can run in parallel within the same year. MP Check performs screening and routes people onward, and the treating clinician decides what happens next.
Which criteria actually separate the two approaches side by side?
Several criteria separate a longevity-oriented checkup from a routine periodic screening, and each matters for a different reason. The primary goal sets the visit's purpose, the trigger sets its timing, the breadth of measures sets how much is sampled, who initiates sets who drives it, the setting sets the logistical cost, and the output sets what you walk away with.
| Criterion | Longevity-oriented checkup | Routine periodic screening |
|---|---|---|
| Primary goal | Track health markers over time | Early detection of defined risks ahead of symptoms |
| Trigger | Personal risk profile, family history, questionnaire | Calendar interval tied to age and policy terms |
| Breadth of measures | Wide biometric panel, which can include resting metabolic rate (RMR) | Core blood and urine tests |
| Who initiates | The individual, or a premium club or benefits programme | The individual, employer or insurer under a periodic clause |
| Typical setting | Clinic, or home and office with a mobile kit such as MP Check's | Clinic, hospital day or workplace campaign |
| Output | Interpreted findings and follow-up priorities | Results, with routing onward where needed |
The trigger row causes the most confusion, because calendar-driven periodic tests and risk-driven checkups can share many measures. The output row is where the two diverge in practice. MP Check addresses the setting row: it brings clinical screening to the home or office, using a finger-prick capillary blood draw.
Who tends to consider a longevity checkup, and when is routine screening enough?
Whether a longevity checkup adds anything over routine screening depends on the person's starting point. For anyone weighing the two formats in 2026, a useful question to take to a doctor is whether a broader, questionnaire-built baseline would change what they monitor.
Situations people commonly raise with their doctor:
- Adults without symptoms who have a family risk history may ask whether a broader early-detection baseline adds anything to their usual periodic checks.
- People with no baseline, such as those who have avoided screening for years because of a fear of needles, may want a starting point to discuss.
- People already in structured follow-up may find that an extra parallel panel duplicates what their clinician already tracks. Here routine care is often enough.
In any of these situations, MP Check's role is the same: clinical screening at home or at the workplace, followed by routing the person onward to their treating physician.
What happens after the results, and who turns findings into care?
What happens after the results matters as much as the visit itself. MP Check performs early-detection screening and routes people onward when a result needs attention.
The sequence with MP Check:
- Complete the personal protocol. A questionnaire sets which tests run, so only the tests the person needs are included.
- Review the results with a specialist. Per MP Check, most results are interpreted on site, including a summary call with a specialist physician.
- Follow up with the treating physician. MP Check routes people onward when a result needs attention.
How should you evaluate the credibility of a screening programme before booking?
Judge a screening programme by criteria you can verify, not by promotional claims. Questions to ask any provider:
- What can this panel detect, and what are its limits? A provider that cannot state the boundaries of its panel is not describing a screening service.
- Who interprets the results with you? Ask whether a physician reviews the findings and explains what needs follow-up.
- Are the devices certified, and how are they validated? Ask whether the instruments carry recognised regulatory approval, such as FDA or CE, and who validated them.
- How are false positives and incidental findings handled? Ask what happens next when a result is borderline or unexpected.
- What happens to your data? Ask who stores it and who can access it.
A provider's openness about its limits is useful evidence in itself. One that can describe its pathway for borderline and incidental findings has already thought that pathway through.
Frequently Asked Questions
What is the difference between a longevity checkup and a routine periodic screening test?
A routine periodic screening runs a standard panel on a fixed schedule. A longevity-oriented checkup covers the same preventive ground but widens the panel and tracks it over time, with measures such as RMR (resting metabolic rate). MP Check builds a personal screening protocol from a questionnaire, so each person gets only the tests they need.
How broad is the panel in a single visit?
According to MP Check, its screening covers over 30 biometric parameters and a broad range of tests, including blood, urine and heart-function tests. The questionnaire narrows that range to the tests a given person needs, so two colleagues screened on the same day may get different protocols. Per MP Check, every device carries FDA and/or CE approval, and the devices are Sheba-validated. Sheba Medical Center is also a part-owner and validator of MP Check. Separately, the Jerusalem Post reported that MP Check technology was integrated into Sheba Medical Center's "Beyond" virtual hospital.
Does health insurance reimburse this kind of screening?
Per MP Check, private health insurance can reimburse up to 80%, depending on the policy's periodic-screening or preventive-medicine clause. One example is Clal Insurance's "Consultations and Examinations" rider, which refunds 80% of actual cost, up to ₪300 per test and ₪1,200 per insurance year, for insured people over 45. Other policies set their own terms, so the clause in your own contract decides what is refunded. The PAP smear, a cervical cancer screening test and one of MP Check's women's health tests, is reimbursed separately.
Why does a finger-prick sample matter, and is fasting required?
MP Check draws capillary blood: per MP Check, 9-10 drops taken from a finger prick rather than from a vein. That blood draw involves no needle, no vein puncture and no fasting, which matters for people whose fear of needles has kept them away from screening. For any other test in your personal protocol, ask about preparation when you book. The finger-prick method also makes home and office screening practical. Per MP Check, a nationwide mobile kit reaches the periphery, the Arab sector and company offices.
How long does the appointment take, and when do results arrive?
According to Insurtech Israel, a full MP Check test takes about 20 minutes, processing time has been cut from weeks to days, and 86% of insured patients preferred MP Check's testing process over standard screening. Per MP Check, most results are interpreted on site, including a summary call with a specialist physician.
What does an employer get out of running screening on site?
MP Check offers employers an anonymous organisational health dashboard, plus evidence for ESG / B Corporation reporting. Because the mobile kit comes to the office, employees do not lose a whole day at a hospital, a common complaint from HR welfare teams. Insurtech Israel reported that MP Check signed an agreement with Teva under which Teva employees undergo periodic screening tests at the workplace.
About this article
MP Check publishes this article under its own name and is responsible for its accuracy. Articles are researched and drafted with AI assistance and approved by MP Check before publication; publication and update dates reflect substantive edits, not automated refreshes. Last updated: 2026-11-01